EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous system infiltration and utility of CD7 versus CADM1 flowcytometric plots of cerebrospinal fluid

Koji Jimbo, Tomohiro Ishigaki, Masataka Sakashita, Shohei Andoh, Hirona Ichimura, Ayumu Ito, Kazuaki Yokoyama, Aki Sato, Takahiro Fukuda, Kaoru Uchimaru, Yasuhito Nannya

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06186-4 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Hematology, 2025. Verfasst von Koji Jimbo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Leukemia-Lymphoma, Adult T-Cell, Antigens, CD7, Flow Cytometry, Central Nervous System Neoplasms. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prognosis of adult T-cell leukemia/lymphoma (ATL) with primary central nervous system (CNS) involvement has been unclear since the advent of new therapies. Recently, we have shown that flow cytometric CD7/CADM1 analysis of CD4 + cells (HAS-Flow) is useful to detect ATL cells that are not morphologically diagnosed as ATL cells. We investigated the role of CNS involvement in ATL using cytology and HAS-Flow by analyzing cerebrospinal fluid (CSF) from 73 aggressive ATL cases. Based on the findings in CSF, the study subjects were classified into CNS + (cytologically malignant, n = 18), CNS- (cytologically non-malignant and ATL cell population negative in HAS-Flow, n = 44), and CNS-Micro (cytologically non-malignant and ATL cell population positive in HAS-Flow, n = 11) groups. As expected, the CNS + group had a shorter overall survival than the CNS- groups ( P < 0.001). However, the CNS-Micro group showed no adverse impact on overall survival compared to the CNS- group ( P = 0.506), even without additional CNS-targeted treatments. HAS-Flow also demonstrated clinical utility in the diagnosis of CSF lesions in ATL patients with cerebral white matter lesions and in the detection of ATL cells on post-treatment CSF examination in patients with CNS involvement. Our study demonstrates that ATL with CNS involvement have a poor prognosis and that CSF HAS-Flow is useful to assist in the diagnosis of suspected CNS involvement and to detect ATL cells with high sensitivity after treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia-Lymphoma, Adult T-CellAntigens, CD7Flow CytometryCentral Nervous System NeoplasmsCell Adhesion Molecule-1HumansMiddle AgedFemaleMaleAdultAgedPrognosisAged, 80 and over

Stichwörter der Autor:innen

Adult T-cell leukemia/lymphoma (ATL)Central nervous system infiltrationCerebrospinal fluidFlow cytometry

Substanzen

Antigens, CD7CADM1 protein, humanCell Adhesion Molecule-1

Autor:innen und Institutionen

  • Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Laboratory Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. ynanya@g.ecc.u-tokyo.ac.jp.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • The University of Tokyo

Zitieren

APA

Jimbo, K., Ishigaki, T., Sakashita, M., Andoh, S., Ichimura, H., Ito, A., Yokoyama, K., Sato, A., Fukuda, T., Uchimaru, K., & Nannya, Y. (2025). Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous system infiltration and utility of CD7 versus CADM1 flowcytometric plots of cerebrospinal fluid. Annals of Hematology. https://doi.org/10.1007/s00277-025-06186-4

Vancouver

Jimbo K, Ishigaki T, Sakashita M, Andoh S, Ichimura H, Ito A, et al. Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous system infiltration and utility of CD7 versus CADM1 flowcytometric plots of cerebrospinal fluid. Annals of Hematology. 2025. doi:10.1007/s00277-025-06186-4

BibTeX
@article{Jimbo2025,
  author = {Jimbo, Koji and Ishigaki, Tomohiro and Sakashita, Masataka and Andoh, Shohei and Ichimura, Hirona and Ito, Ayumu and Yokoyama, Kazuaki and Sato, Aki and Fukuda, Takahiro and Uchimaru, Kaoru and Nannya, Yasuhito},
  title = {Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous system infiltration and utility of CD7 versus CADM1 flowcytometric plots of cerebrospinal fluid},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06186-4}
}
Kostenlos starten →